Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00002549
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 1,520
Testing effectiveness (Phase 2)Active Not RecruitingNCT06232655
What this trial is testing

Cladribine Venetoclax in Monocytic AML

Who this might be right for
Acute Myeloid Leukemia
University of Colorado, Denver 10
Early research (Phase 1)Looking for participantsNCT04318678
What this trial is testing

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

Who this might be right for
AML/MDSB-ALLT-ALL+1 more
St. Jude Children's Research Hospital 108
Post-approval studies (Phase 4)Active Not RecruitingNCT05144243
What this trial is testing

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 44
Testing effectiveness (Phase 2)Looking for participantsNCT07008638
What this trial is testing

Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid LeukemiaTP53
Masonic Cancer Center, University of Minnesota 32
Post-approval studies (Phase 4)Study completedNCT01041040
What this trial is testing

LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloblastic Leukemia
PETHEMA Foundation 200
Not applicableEnded earlyNCT02435550
What this trial is testing

ICare for Cancer Patients

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaAcute Myelogenous Leukemia+4 more
University of Florida 136
Testing effectiveness (Phase 2)Study completedNCT01154816
What this trial is testing

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Acute Lymphoblastic Leukemia+8 more
Children's Oncology Group 118
Not applicableStudy completedNCT02662933
What this trial is testing

Investigating the Relationship Between Physical Function, Comorbidity and Cytogenetic Risk Group in Older Adults With Acute Myelogenous Leukemia (AML)

Who this might be right for
ACUTE MYELOGENOUS LEUKEMIA
Wake Forest University Health Sciences 82
Large-scale testing (Phase 3)Study completedNCT06211452
What this trial is testing

Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia

Who this might be right for
AMLPediatric AML
Grupo Argentino de Tratamiento de la Leucemia Aguda 258
Testing effectiveness (Phase 2)Looking for participantsNCT05564390
What this trial is testing

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic Therapy+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05436418
What this trial is testing

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Who this might be right for
Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 260
Not applicableEnded earlyNCT01463410
What this trial is testing

Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Promyelocytic Leukemia (APL)Refractory Anemia With Excess of Blasts (RAEB)
Skyline Diagnostics BV 264
Not applicableNot Yet RecruitingNCT07762508
What this trial is testing

VABu Conditioning Regimen in Allo-HSCT for AML Patients

Who this might be right for
Leukemia, Myeloid, Acute(AML)Hematopoietic Stem Cell Transplantation (HSCT)
The First Affiliated Hospital of Soochow University 42
Testing effectiveness (Phase 2)Ended earlyNCT00129948
What this trial is testing

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
SGX Pharmaceuticals, Inc. 211
Early research (Phase 1)Ended earlyNCT00907517
What this trial is testing

Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)

Who this might be right for
Myelogenous Leukemia, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Lymphoblastic, Acute, Philadelphia-Positive+1 more
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Looking for participantsNCT06372717
What this trial is testing

Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

Who this might be right for
Acute Myeloid Leukemia RefractoryMyelodysplastic Syndrome Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts+2 more
Apollo Therapeutics Ltd 100
Testing effectiveness (Phase 2)Study completedNCT00849147
What this trial is testing

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 55
Post-approval studies (Phase 4)Study completedNCT01200355
What this trial is testing

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Memorial Sloan Kettering Cancer Center 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417
What this trial is testing

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more
M.D. Anderson Cancer Center 204
Next Page
2,000